Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stolte

Showing results (481-490 of 538) with videos related to

Pageof 54
Sort By:
Der Pathologe|September 1, 1992
[Classification of erosions of the stomach. Results of a meeting of the Study Group of Gastroenterologic Pathology of the German Society of Pathology 23 November 1991 in Frankfurt/Main]F Borchard, P Malfertheiner, A von Herbay, et al.
The American Journal of Gastroenterology|April 14, 2000
The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infectionP Bercík, E F Verdú, D Armstrong, et al.
Cancer|April 13, 2000
Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relativesJ Yu, S Miehlke, M P Ebert, et al.
Alimentary Pharmacology & Therapeutics|May 3, 2000
The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjectsG Dorta, M Nicolet, D Vouillamoz, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 19, 2007
Circumferential and axial distribution of esophageal mucosal damage in reflux diseaseA Edebo, M Vieth, W Tam, et al.
Gut|August 1, 1997
Non-alcoholic duct destructive chronic pancreatitisN Ectors, B Maillet, R Aerts, et al.
Scandinavian Journal of Gastroenterology|November 24, 1999
Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritisM Breidert, S Miehlke, A Glasow, et al.
Alimentary Pharmacology & Therapeutics|February 1, 2005
A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitisY Marakhouski, B Fixa, J Holomán, et al.
Digestive Diseases (Basel, Switzerland)|September 24, 2004
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?M Vieth, U Peitz, J Labenz, et al.
Histopathology|January 1, 1996
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel diseaseS C Bischoff, J Wedemeyer, A Herrmann, et al.
Pageof 54

Showing results (481-490 of 538) with videos related to

Sort By:
Pageof 54
Der Pathologe|September 1, 1992
[Classification of erosions of the stomach. Results of a meeting of the Study Group of Gastroenterologic Pathology of the German Society of Pathology 23 November 1991 in Frankfurt/Main]F Borchard, P Malfertheiner, A von Herbay, et al.
The American Journal of Gastroenterology|April 14, 2000
The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infectionP Bercík, E F Verdú, D Armstrong, et al.
Cancer|April 13, 2000
Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relativesJ Yu, S Miehlke, M P Ebert, et al.
Alimentary Pharmacology & Therapeutics|May 3, 2000
The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjectsG Dorta, M Nicolet, D Vouillamoz, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 19, 2007
Circumferential and axial distribution of esophageal mucosal damage in reflux diseaseA Edebo, M Vieth, W Tam, et al.
Gut|August 1, 1997
Non-alcoholic duct destructive chronic pancreatitisN Ectors, B Maillet, R Aerts, et al.
Scandinavian Journal of Gastroenterology|November 24, 1999
Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritisM Breidert, S Miehlke, A Glasow, et al.
Alimentary Pharmacology & Therapeutics|February 1, 2005
A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitisY Marakhouski, B Fixa, J Holomán, et al.
Digestive Diseases (Basel, Switzerland)|September 24, 2004
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?M Vieth, U Peitz, J Labenz, et al.
Histopathology|January 1, 1996
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel diseaseS C Bischoff, J Wedemeyer, A Herrmann, et al.
Pageof 54